| Keyword search (4,164 papers available) | ![]() |
"Rabi DM" Authored Publications:
| Title | Authors | PubMed ID | |
|---|---|---|---|
| 1 | Management of brain-heart multimorbidity: a clinical practice guideline | Edwards JD; Li Z; McFarlane P; Rabi DM; Gilbert J; Bajaj HS; MacIntosh BJ; Bittman J; Feldman RD; Dresser G; Terenzi K; Swartz R; Gabor J; Pearson GJ; Selby P; Wharton S; Warburton DER; Pakhalé S; Styra R; Baker B; Tu K; Hawkins M; Stone JA; Vaillancourt T; Poon S; Virani SA; Jain R; Jones PH; Sandhu RK; Ganesh A; Andrade JG; Stern S; Habert J; Rivard L; Roumeliotis P; Udell JA; Campbell T; Bacon SL; Trudeau L; Keshavjee K; Pham T; Cheng G; Lewis KB; Maar M; Stacey D; Oldenburg B; Dhukai AR; Pasricha SV; Sh | 41912243 HKAP |
| 2 | Ligne directrice C-CHANGE pour l’harmonisation des lignes directrices nationales de prévention et de prise en charge des maladies cardiovasculaires en contexte de soins primaires au Canada: mise à jour 2022 | Jain R; Stone JA; Agarwal G; Andrade JG; Bacon SL; Bajaj HS; Baker B; Cheng G; Dannenbaum D; Gelfer M; Habert J; Hickey J; Keshavjee K; Kitty D; Lindsay P; L' Abbé MR; Lau DCW; Macle L; McDonald M; Nerenberg K; Pearson GJ; Pham T; Poppe AY; Rabi DM; Sherifali D; Selby P; Smith E; Stern S; Thanassoulis G; Terenzi K; Tu K; Udell J; Virani SA; Ward RA; Warburton DER; Wharton S; Zymantas J; Hua-Stewart D; Liu PP; Tobe SW; | 36623864 HKAP |
| 3 | Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update | Jain R; Stone JA; Agarwal G; Andrade JG; Bacon SL; Bajaj HS; Baker B; Cheng G; Dannenbaum D; Gelfer M; Habert J; Hickey J; Keshavjee K; Kitty D; Lindsay P; L' Abbé MR; Lau DCW; Macle L; McDonald M; Nerenberg K; Pearson GJ; Pham T; Poppe AY; Rabi DM; Sherifali D; Selby P; Smith E; Stern S; Thanassoulis G; Terenzi K; Tu K; Udell J; Virani SA; Ward RA; Warburton DER; Wharton S; Zymantas J; Hua-Stewart D; Liu PP; Tobe SW; | 36343954 HKAP |
| 4 | Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. | Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, Butalia S, Leung AA, Harris KC, Cloutier L, Zarnke KB, Ruzicka M, Hiremath S, Feldman RD, Tobe SW, Campbell TS, Bacon SL, Nerenberg KA, Dresser GK, Fournier A, Burgess E, Lindsay P, Rabkin SW, Prebtani APH, Grover S, Honos G, Alfonsi JE, Arcand J, Audibert F, Benoit G, Bittman J, Bolli P, Côté AM, Dionne J, Don-Wauchope A, Edwards C, Firoz T, Gabor JY, Gilbert RE, Grégoire JC, Gryn SE, Gupta M, Hannah-Shmouni F, Hegele RA, Herman RJ, H | 32389335 HKAP |
| 5 | Prolonged hypothalamic-pituitary-adrenal axis activation after acute coronary syndrome in the GENESIS-PRAXY cohort. | Tang AR, Rabi DM, Lavoie KL, Bacon SL, Pilote L, Kline GA | 28969495 HKAP |
| 6 | Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update. | Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L'Abbe M, Lau DCW, Leiter LA, O'Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP | 30301743 HKAP |
| Title: | Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. | ||||
| Authors: | Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, Butalia S, Leung AA, Harris KC, Cloutier L, Zarnke KB, Ruzicka M, Hiremath S, Feldman RD, Tobe SW, Campbell TS, Bacon SL, Nerenberg KA, Dresser GK, Fournier A, Burgess E, Lindsay P, Rabkin SW, Prebtani APH, Grover S, Honos G, Alfonsi JE, Arcand J, Audibert F, Benoit G, Bittman J, Bolli P, Côté AM, Dionne J, Don-Wauchope A, Edwards C, Firoz T, Gabor JY, Gilbert RE, Grégoire JC, Gryn SE, Gupta M, Hannah-Shmouni F, Hegele RA, Herman RJ, H | ||||
| Link: | https://www.ncbi.nlm.nih.gov/pubmed/32389335?dopt=Abstract | ||||
| DOI: | 10.1016/j.cjca.2020.02.086 | ||||
| Publication: | The Canadian journal of cardiology | ||||
| Keywords: | |||||
| PMID: | 32389335 | Category: | Can J Cardiol | Date Added: | 2020-05-12 |
| Dept Affiliation: |
HKAP
1 Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: ip3@ualberta.ca. 2 Departments of Family Medicine and Community Health Services, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. 3 Division of Nephrology, Department of Medicine, McGill University and Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. 4 Department of Pediatrics and Centre for Outcomes Research and Evaluation, McGill University, and Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. 5 Department of Medicine, University of Calgary, Libin Cardiovascular Institute of Alberta, and Alberta Kidney Disease Network, Calgary, Alberta, Canada. 6 Departments of Medicine and Community Health Sciences, O'Brien Institute for Public Health, and Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada. 7 Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, Calgary, Alberta, Canada. 8 Children's Heart Centre, BC Children's Hospital, and Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada. 9 Department of Nursing, Université du Québec à Trois-Rivières, Trois-Rivières, Quebec, Canada. 10 O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. 11 Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. 12 University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. 13 Winnipeg Regional Health Authority and the University of Manitoba, Winnipeg, Manitoba, Canada. 14 Department of Medicine, University of Toronto, and Northern Ontario School of Medicine, Sudbury, Ontario, Canada. 15 Department of Psychology, University of Calgary, Calgary, Alberta, Canada. 16 Department of Health, Kinesiology, and Applied Physiology, Concordia University, and Montreal Behavioural Medicine Centre, CIUSSS-NIM, Montréal, Quebec, Canada. 17 Division of General Internal Medicine, Departments of Medicine, Obstetrics and Gynecology, and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. 18 Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. 19 Centre Hospitalier Universitaire Sainte-Justine, Department of Pediatrics, Université de Montréal, Montréal, Quebec, Canada. 20 Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. 21 Heart and Stroke Foundation of Canada, Ottawa, Ontario, Canada. 22 Vancouver Hospital, University of British Columbia, Vancouver, British Columbia, Canada. 23 Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. 24 Department of Medicine, McGill University, Montreal, Quebec, Canada. 25 Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. 26 Faculty of Health Sciences, University of Ontario Institute of Technology, Oshawa, Ontario, Canada. 27 Department of Obstetrics and Gynecology, CHU Sainte-Justine, Université de Montréal, Quebec, Canada. 28 Service de néphrologie, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montr |
||||
Description: |
Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2020 May;36(5):596-624 Authors: Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, Butalia S, Leung AA, Harris KC, Cloutier L, Zarnke KB, Ruzicka M, Hiremath S, Feldman RD, Tobe SW, Campbell TS, Bacon SL, Nerenberg KA, Dresser GK, Fournier A, Burgess E, Lindsay P, Rabkin SW, Prebtani APH, Grover S, Honos G, Alfonsi JE, Arcand J, Audibert F, Benoit G, Bittman J, Bolli P, Côté AM, Dionne J, Don-Wauchope A, Edwards C, Firoz T, Gabor JY, Gilbert RE, Grégoire JC, Gryn SE, Gupta M, Hannah-Shmouni F, Hegele RA, Herman RJ, Hill MD, Howlett JG, Hundemer GL, Jones C, Kaczorowski J, Khan NA, Kuyper LM, Lamarre-Cliche M, Lavoie KL, Leiter LA, Lewanczuk R, Logan AG, Magee LA, Mangat BK, McFarlane PA, McLean D, Michaud A, Milot A, Moe GW, Penner SB, Pipe A, Poppe AY, Rey E, Roerecke M, Schiffrin EL, Selby P, Sharma M, Shoamanesh A, Sivapalan P, Townsend RR, Tran K, Trudeau L, Tsuyuki RT, Vallée M, Woo V, Bell AD, Daskalopoulou SS Abstract PMID: 32389335 [PubMed - in process] |



